Canada Life
FMTX

Canada Life’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Canada Life’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,148
Closed -$23K – 2420
2022
Q3 		$23K Hold
1,148
– – ﹤0.01% 2245
2022
Q2 		$8K Hold
1,148
– – ﹤0.01% 2393
2022
Q1 		$11K Hold
1,148
– – ﹤0.01% 2431
2021
Q4 		$16K Hold
1,148
– – ﹤0.01% 2415
2021
Q3 		$27K Hold
1,148
– – ﹤0.01% 2384
2021
Q2 		$29K Hold
1,148
– – ﹤0.01% 2416
2021
Q1 		$32K Hold
1,148
– – ﹤0.01% 2433
2020
Q4 		$40K Buy
+1,148
New +$50K ﹤0.01% 2363

Canada Life's FMTX Position: Q4 2022 in Review

Canada Life sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 1,148 shares — an estimated $23K sold.

Canada Life first reported a position in FMTX in Q4 2020 and held it in 8 quarters. The position peaked at $40K in Q4 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Canada Life reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Canada Life sold 1,148 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $23K.
  • Canada Life first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Canada Life's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $40K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Canada Life's 13F filing for Q4 2022, filed 10 Feb 2023.